Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0007 Transporter Info | ||||
| Gene Name | SLC47A1 | ||||
| Transporter Name | Multidrug and toxin extrusion protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Ketoconazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 456201 | ||||
| Docking Score | -9.513 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C26H28Cl2N4O4 | ||||
| Molecular Weight | 531.4 | ||||
| Canonical SMILES |
CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
|
||||
| InChI |
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1
|
||||
| InChIKey | XMAYWYJOQHXEEK-OZXSUGGESA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.3 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Plazomicin | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 42613186 | ||||
| Docking Score | -9.496 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H48N6O10 | ||||
| Molecular Weight | 592.7 | ||||
| Canonical SMILES |
C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CNCCO)N)N)NC(=O)[C@H](CCN)O)O
|
||||
| InChI |
InChI=1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1
|
||||
| InChIKey | IYDYFVUFSPQPPV-PEXOCOHZSA-N | ||||
| Pharmaceutical Properties | Xlogp | -6.2 | Rotatable Bond Count | 13 | |
| Hydrogen Bond Donor Count | 11 | Hydrogen Bond Acceptor Count | 15 | ||
| Xenobiotic Name | Astemizole Drug Info | ||||
| Xenobiotic Type | Drug Withdrawn | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2247 | ||||
| Docking Score | -9.486 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C28H31FN4O | ||||
| Molecular Weight | 458.6 | ||||
| Canonical SMILES |
COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
|
||||
| InChI |
InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
|
||||
| InChIKey | GXDALQBWZGODGZ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.